Abstract
The development of the radical prostatectomy over the past 20 years has been marked by an improved ability to extirpate the tumor, combined with a substantially reduced morbidity due to the effects of the operation. A continuum of anatomic discoveries have occurred over the past 30 years pioneered to a significant extent by Walsh [1,2]. These advances in our understanding of the anatomy of the pelvic floor musculature and the nerve and vascular innervation have led to marked improvements in postoperative urinary control and erectile function, two of the more common side effects from this operation. In addition, the greater number of cases being performed by urologic surgeons has contributed to better surgical results overall.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Reiner WG, Walsh PC: An anatomical approach to the surgical management of the dorsal vein and Santorini’s plexus during radical retropubic surgery. J Urol 1979, 121: 198–200.
Walsh PC, Donker PJ: Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982, 128: 492–497.
Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 2002, 52: 23–47.
Bubolz T, Wasson JH, Lu-Yao G, Barry MJ: Treatments for prostate cancer in older men: 1984–1997. Urology 2001, 58: 977–982.
Gerber GS, Thisted RA, Scardino PT, et al.: Results of radical prostatectomy in men with clinically localized prostate cancer. DAMA 1996, 276: 615–619.
Han M, Partin AW, Pound CR, et al.: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 2001, 28: 555–565.
Hull GW, Rabbani F, Abbas F, et al.: Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002, 167: 528–534.
Kattan MW, Eastham JA, Stapleton AM, et al.: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998, 90: 766–771.
Stapleton AMF, Scardino PT: Nerve-sparing radical retropubic prostatectomy. In Atlas of Clinical Urology, vol II: The Prostate. Edited by Vaughan ED, Jr., Perlmutter AR. Philadelphia: Current Medicine; 1999: 11. 1–11. 11
Scardino PT, Weaver R, Hudson MA: Early detection of prostate cancer. Hum Pathol 1992, 23: 211–222.
Albertsen PC, Fryback DG, Storer BE, et al.: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995, 274: 626–631.
Huland H: Radical prostatectomy: options and issues. Eur Urol 2001, 39 (suppl 1): 3–9.
Chodak GW, Thisted RA, Gerber GS, et al.: Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994, 330: 242–248.
Fleming C, Wasson JH, Albertsen PC, et al.: A decision analysis of alternative treatment strategies for clinically localized prostate cancer: Prostate Patient Outcomes Research Team. DAMA 1993, 269:2650–2658.
Partin AW, Mangold LA, Lamm DM, et al.: Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001, 58:843–848.
Zincke H, Oesterling JE, Blute ML, et al.: Long-term (15 years) results after radical prostatectomy for clinically localized (stageT2c or lower) prostate cancer. J Urol 1994, 152:1850–1857.
Catalona WJ, Smith DS: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. Uro/ 1998, 160: 2428–2434.
Ohori M, Wheeler TM, Dunn JK, et al.: The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 1994, 151:1558–1564.
Smith DS, Catalona WJ: The nature of prostate cancer detected through prostate specific antigen based screening.] Urol 1994, 152: 1732–1736.
Epstein JI, Walsh PC, Carmichael M, Brendler CB: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. DAMA 1994, 271: 368–374.
Messing EM, Manola J, Sarosdy M, et al.: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999, 341:1781–1788.
Guillonneau B, Cathelineau X, Doublet JD, Vallancien G: Laparoscopic radical prostatectomy: the lessons learned. J Endourol 2001, 15: 441–445.
Albertsen PC, Hanley JA, Harlan LC, et al.: The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J Urol 2000, 163:1138–1143.
Eastham JA, Scardino PT: Radical prostatectomy. In Campbell’s Urology, edn 6. Edited by Walsh PC, Gittes RF, Perlmutter AD, Stamey TA. Philadelphia: WB Saunders Company; 1996: 2547–2564.
Goad JR, Eastham JA, Fitzgerald KB, et al.: Radical retropubic prostatectomy: limited benefit of autologous blood donation. J Urol 1995, 154: 2103–2109.
Eastham JA, Kattan MW, Rogers E, et al.: Risk factors for urinary incontinence after radical prostatectomy. J Urol 1996, 156: 1707–1713.
Cisek LJ, Walsh PC: Thromboembolic complications following radical retropubic prostatectomy: influence of external sequential pneumatic compression devices. Urology 1993, 42: 406–408.
Bigg SW, Catalona WJ: Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy: a prospective trial. Urology 1992, 39: 309–313.
Gottschalk A, Smith DS, Jobes DR, et al.: Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial. JAMA 1998, 279: 1076–1082.
Lerner SE, Blute ML, Lieber MM, Zincke H: Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. Oncology 1995, 9: 379–382.
Dillioglugil O, Leibman BD, Leibman NS, et al.: Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 1997, 157: 1760–1767.
Andriole GL, Smith DS, Rao G, et al.: Early complications of contemporary anatomical radical retropubic prostatectomy. J Urol 1994, 152: 1858–1860.
Surya BV, Provet J, Johanson KE, Brown J: Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol 1990, 143: 755–758.
Fowler FJ Jr, Barry MJ, Lu-Yao G, et al.: Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (updated June 1993). Urology 1993, 42: 622–629.
Walsh PC: Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 2000, 163: 1802–1807.
Quinlan DM, Epstein JI, Carter BS, Walsh PC: Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991, 145: 998–1002.
Catalona WJ, Carvalhal GF, Mager DE, Smith DS: Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. Urol 1999, 162: 433–438.
Walsh PC: Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol 2000, 164: 242.
Rabbani F, Stapleton AM, Kattan MW, et al.: Factors predicting recovery of erections after radical prostatectomy. J Urol 2000, 164: 1929–1934.
Zippe CD, Kedia AW, Kedia K, et al.: Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology 1998, 52: 963–966.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Current Medicine, Inc.
About this chapter
Cite this chapter
Jarrard, D.F. (2003). Nerve-sparing Radical Retropubic Prostatectomy. In: Bruskewitz, R.C. (eds) Atlas of the Prostate. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6505-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6505-5_11
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4615-6507-9
Online ISBN: 978-1-4615-6505-5
eBook Packages: Springer Book Archive